pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 545 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
glenzocimab
Acute Ischemic Stroke
Platelet glycoprotein VI
Acticor Biotech SAS
0 catalysts
Phase 3
glufosfamide
glufosfamide [INN]
Metastatic Adenocarcinoma of The Pancreas
Eleison Pharmaceuticals Inc
0 catalysts
Phase 3
glyburide
Cirara (glyburide)
Diabetes
Sulfonylurea receptor 1, Kir6.2
← prev
page 11 of 19
next →
131
Pain89
Neurology1
$ETONEton Pharmaceuticals, Inc.
0 catalysts
Phase 3
gotistobart
Non-Small Cell Lung Cancer
OncoC4 Inc
0 catalysts
Phase 3
gusacitinib hydrochloride
Hand Dermatitis
$SNYSanofi
0 catalysts
Phase 3
hypericin sodium
Cutaneous T-Cell Lymphoma
$SNGXSOLIGENIX, INC.
0 catalysts
Phase 3
ianalumab
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Tumor necrosis factor receptor superfamily member 13C
$NVSNOVARTIS AG
0 catalysts
Phase 3
ibramvibart
ibramvibart [INN]
Coronavirus Disease 2019 (COVID-19)
$IVVDInvivyd, Inc.
0 catalysts
Phase 3
ibrilatazar
ibrilatazar [INN]
Metastatic Pancreatic Cancer
Ability Pharmaceuticals SL
0 catalysts
Phase 3
ibudilast
ibudilast [INN]
Amyotrophic Lateral Sclerosis
$MNOVMEDICINOVA INC
0 catalysts
Phase 3
ibutamoren mesylate
Oratrope (ibutamoren mesylate)
Growth Hormone Deficiency
Growth hormone secretagogue receptor type 1
Lumos Pharma Inc
0 catalysts
Phase 3
ibuzatrelvir
Coronavirus Disease 2019 (COVID-19)
$PFEPFIZER INC
0 catalysts
Phase 3
iltamiocel
Stress Urinary Incontinence
Cook MyoSite Inc
0 catalysts
Phase 3
imeroprubart
Rheumatoid Arthritis
$IMVTImmunovant, Inc.
0 catalysts
Phase 3
inaxaplin
Focal Segmental Glomerulosclerosis (FSGS)
$VERXVertex, Inc.
0 catalysts
Phase 3
influenza (quadrivalent) vaccine
Influenzavirus A Infections
$PFEPFIZER INC
0 catalysts
Phase 3
influenza (trivalent) vaccine
Seasonal Influenza
$NVAXNOVAVAX INC
0 catalysts
Phase 3
iodine i 131 apamistamab
Iomab-B (iodine i 131 apamistamab)
Refractory Acute Myeloid Leukemia
$ATNMActinium Pharmaceuticals, Inc.
0 catalysts
Phase 3
ipilimumab + nivolumab
Opdivo + Yervoy (ipilimumab + nivolumab)
Gastric Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 3
ipsoprubart
ipsoprubart [INN]
Hemophagocytic Lymphohistiocytosis
Electra Therapeutics Inc
0 catalysts
Phase 3
iron sucrose + stannic protoporfin
Acute Renal Failure (ARF) (Acute Kidney Injury)
Renibus Therapeutics Inc
0 catalysts
Phase 3
isoflurane
Isoflurane (isoflurane)
Sedation
Potassium channel subfamily K member 2Potassium channel subfamily K member 9
Sedana Medical AB
0 catalysts
Phase 3
itepekimab
Chronic Obstructive Pulmonary Disease (COPD)
Interleukin-33
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 3
ivarmacitinib sulfate
Ulcerative Colitis
Reistone Biopharma Co Ltd
0 catalysts
Phase 3
ivospemin hydrochloride
Pancreatic Ductal Adenocarcinoma
Panbela Therapeutics Inc
0 catalysts
Phase 3
ixoberogene soroparvovec
Wet (Neovascular / Exudative) Macular Degeneration
Adverum Biotechnologies Inc
0 catalysts
Phase 3
izalontamab brengitecan
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 3
larsucosterol sodium
Alcoholic Hepatitis
$BHCBausch Health Companies Inc.
0 catalysts
Phase 3
laruparetigene zovaparvovec
Retinitis Pigmentosa (Retinitis)
Beacon Therapeutics Ltd
0 catalysts
Phase 3
lasofoxifene tartrate
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Estrogen receptor
$LONALeonaBio, Inc.
0 catalysts